No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: J&J Abiraterone going generic

Loses case to prevent generic ! Would this prompt them to move on Zenith ? Maybe start a bidding contest with PFE ?The prostate cancer franchise worth ... ? 

 

 

 

Share
New Message
Please login to post a reply